Suven Gets Product Patents for Neurodegenerative Disorders
Suven Life Sciences has been granted two product patents by Australia and one by Singapore corresponding to a new chemical entity (NCE) for the treatment of disorders associated with neurodegenerative diseases. These patents are valid till 2034, the company said in a stock exchange filing.
“We are pleased by the grant of these patents to Suven for our pipeline of molecules in the CNS arena, which are being developed for cognitive disorders with high unmet medical need with a huge market potential globally,” Suven’s CEO, Mr. Venkat Jasti said. The granted claims of the patents are being developed as therapeutic agents useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson’s and schizophrenia, the filing added.
2026-10-18
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Global Bunker Fuel Deficit Widens, Raising the Risk of a Second Cost Shock for Chemical Shipping
-
"No available slots" returns as global shipping rates skyrocket amid multiple factors
-
“Soaring Sulfuric Acid, Tightening Ore Supplies”: The High-Stakes Battle Behind the Titanium Dioxide Price Surge
-
Japanese Plastics Market Accelerates its Shifts to Recycled Materials and Bioplastics
-
Qatar LNG Hit by Attack: 17% Export Capacity Lost, $20 Billion Wiped Out
-
Vietnam Drives ASEAN Towards a Modern Economy
-
Amazon Turns Lilly’s Weight-Loss Pill Into a Retail Logistics Play
-
USDA Puts Fresh Money Into Local Food Markets
-
EU Low-Value Parcel Rules Could Disrupt Chemical Sample Flows
-
EU May Build Industry-Level Trade Barriers Against Chinese Chemicals
Recommend Reading
-
Global Trade Data for Epoxy Resin in 2025 Released: Asia Accounted for $640 Million in Imports, Vietnam Emerges as Top Buyer
-
Shandong’s Export Growth Is 2.8%; This Category Is 19%: Shandong Has a Chokehold on the Upstream of Global Manufacturing
-
Wanhua USA Reaches $7.75 Million Settlement in MDI/TDI Antitrust Lawsuit
-
Can Lotte Chemical's Four Growth Pillars Support Its New Valuation After Spinning Off Basic Chemicals?
-
Mitsubishi Chemical Exits 105,000-Tonne Taiwan MMA Business as China Capacity Reshapes Asian Market
-
Business Society’s Ethanol Market Outlook on September 8, 2026: Strong Consolidation
-
How the Jianxiawo Lithium Mine Is Driving Trends in Lithium Carbonate Prices
-
Business Community September 8, 2026 BDO Market Perspective: Clear Increase
-
Traditional Peak Season Arrives, Palm Oil Prices Expected to Rise in China
-
Production and Sales Pressure Eases; PC Prices Stabilize for Late November